Portfolio Details

Newmarket Strategy

Current

Founded in 2021, Newmarket applies deep market access, commercial and policy expertise to the health and life sciences sector. The team works with clients to assess market opportunities, secure reimbursement from payors, and drive the uptake of health innovations.

A number of characteristics attracted us to invest in the business, including its:

  • Founder focus – the business is founder-run and seeking their first institutional capital event.
  • Pharma Services thesis alignment – our investment follows a proactive thesis to invest into and grow a best of breed independent Market Access provider.
  • International growth opportunity – Market Access is global in nature presenting significant opportunities for Newmarket to continue to internationalize.
  • Need for flexible capital – the founders were seeking a minority investment partner, which aligns well with our flexible capital approach.

Since our investment in Newmarket, the company has completed one add-on acquisition:

Visible Analytics

Health Economics and Outcomes Research (HEOR) and data analytics firm. The partnership enhances Newmarket’s position as a leading independent provider of market access and health policy advice to the life sciences sector.

Investment Contacts

Michael Holgate Partner
View Profile
Learn more about the company
Current
Team
Global Private Equity
Invested Date
January 2025
Status
Active
Location
U.K.

Share

See All Transactions

Related Content

Man in scrubs holding an iPad with icons floating above it.
Baird Capital Invests in Newmarket Strategy

Baird Capital's Global Private Equity Team announced an investment in Newmarket Strategy (Newmarket).

Abstract digital chart with multicolored waves and data points illustrating market volatility and financial analytics.
Portfolio Company Newmarket Strategy Acquires Visible Analytics

Visible Analytics is a specialist consultancy with expertise in health economics and outcomes research (HEOR).